1999
DOI: 10.1038/sj.jhh.1000899
|View full text |Cite
|
Sign up to set email alerts
|

Overview of the outcome trials in older patients with isolated systolic hypertension

Abstract: Aims: Isolated systolic hypertension affects over 8 to 15% of all subjects older than 60 years. In the elderly, systolic hypertension is the major modifiable cardiovascular risk factor. Three placebo-controlled outcome trials on antihypertensive drug treatment of this disorder have been published. The aim of this article was to shortly review each of these three trials and to present the pooled estimates of benefit of antihypertensive drug treatment in isolated systolic hypertension in the elderly. Methods an… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
14
0
2

Year Published

2000
2000
2013
2013

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 48 publications
(18 citation statements)
references
References 22 publications
1
14
0
2
Order By: Relevance
“…4 BP reduction has been shown to be effective in lowering stroke risk in both primary and secondary prevention. [25][26][27] In our study, the estimated risk of stroke at 10 years was lower in patients with elevated BP without diagnosis of HT than in patients with HT previously diagnosed despite slightly higher BP values in the patients without a diagnosis of HT. On stratifying by BP levels according to the classification of the Seventh Report of the Joint National Committee, 10 estimated risk was seen to be greater among the patients with a In the multiple linear regression model, patient age, atrial fibrillation, and LVH were factors of considerable impact on risk estimation in this population in the multivariate analysis.…”
Section: Discussionmentioning
confidence: 62%
“…4 BP reduction has been shown to be effective in lowering stroke risk in both primary and secondary prevention. [25][26][27] In our study, the estimated risk of stroke at 10 years was lower in patients with elevated BP without diagnosis of HT than in patients with HT previously diagnosed despite slightly higher BP values in the patients without a diagnosis of HT. On stratifying by BP levels according to the classification of the Seventh Report of the Joint National Committee, 10 estimated risk was seen to be greater among the patients with a In the multiple linear regression model, patient age, atrial fibrillation, and LVH were factors of considerable impact on risk estimation in this population in the multivariate analysis.…”
Section: Discussionmentioning
confidence: 62%
“…This explanation of our finding is consistent with previous reports indicating that doctors were not inclined to treat elderly people with stage 1 hypertension or with stages 2-3 ISH. [3][4][5] The recently reported positive effects of antihypertensive treatment on elderly patients with stages 2-3 ISH [23][24][25] will probably induce physicians to treat this type of patient in the future. By contrast, the decision to treat elderly people with stage 1 hypertension is less clear-cut because direct evidence of the benefit of antihypertensive therapy in such patients is still lacking.…”
Section: Discussionmentioning
confidence: 99%
“…[1][2][3][4] However, observational studies have shown that awareness, treatment and control of hypertension could be improved, especially in elderly people. [5][6][7][8] Furthermore, the recent recommendations to treat all 9 or part 10,11 of elderly patients with stage 1 hypertension might further increase the gap between the proposed guidelines and actual trends in the management of hypertension.…”
Section: Introductionmentioning
confidence: 99%
“…Since elderly men with isolated systolic hypertension are known to be at high risk of SCD [27] , it is important to note that an overview of the outcome trials in isolated systolic hypertension in the elderly identified a reduction in all-cause mortality of 17%, and myocardial infarction including SCD of 25% [31] . A meta-analysis of randomized controlled trials of blood pressure reduction mostly in middle-aged subjects with diastolic hypertension [32] found a risk reduction of 14% (95 C.I.…”
Section: Hypertension and Left Ventricular Hypertrophymentioning
confidence: 99%